Should you buy Sun Pharma, Grasim, Cipla, Paytm, other stocks today? Here is what brokerages recommend

As Dalal Street enters the May 23 session, brokerages have several stocks on their radar. Here's what Goldman Sachs, Jefferies, Macquarie, JPMorgan, Citi, Morgan Stanley, CLSA, HSBC and Nomura make of stocks such as Sun Pharmaceutical Industries, Grasim Industries, Cipla, and One 97 Communications (Paytm):

Should you buy Sun Pharmaceutical shares?

CLSA has an 'underperform' rating on the Sun Pharmaceutical Industries stock with a target of Rs 1,610, while JPMorgan has maintained an 'overweight' rating on the stock with a target of Rs 1,610.

Jefferies and HSBC have maintained a 'buy' call on the Sun Pharma stock with a target of Rs 1,785 and Rs 1,670, respectivley. Goldman Sachs, on the other side, has maintained a 'sell' call on the stock with a target of Rs 1,270.

Nomura has maintained a 'neutral' rating on Sun Pharma with a target of Rs 1,444.

Should you buy Grasim Industries shares?

Jefferies has maintained a 'buy' call on the Grasim Industries stock with a target of Rs 2,600.

Morgan Stanley has maintained an 'equal-weight' rating on Grasim shares with a target of Rs 2,560.

Should you buy Power Grid shares?

Morgan Stanley has maintained an 'overweight' rating on the Power Grid Corp stock with a target of Rs 296.

Should you buy Jubilant FoodWorks shares?

CLSA has maintained a 'sell' call on the Jubilant FoodWorks stock with a target of Rs 454, HSBC, on the other side, has maintained a 'buy' call on the stock with a target of Rs 570.

Jefferies has maintained a 'hold' call on Jubilant Foodworks shares with a target of Rs 475.

Morgan Stanley has maintained an 'equal-weight' rating on Jubilant Foodworks with a target of Rs 427, while Macquarie has maintained an 'underperform' rating on the stock with a target of Rs 300.

JPMorgan and Goldman Sachs have maintained a 'neutral' rating on Jubilant Foodworks shares with a target of Rs 515 and Rs 480, respectively.

Should you buy Petronet LNG shares?

JPMorgan has maintained an 'overweight' rating on the Petronet LNG stock with a target of Rs 350, while Morgan Stanley has maintained an 'equal-weight' rating on the stock with a target of Rs 239.

Should you buy Ramco Cements shares?

Citi has maintained a 'sell' call on Ramco Cements shares with a target of Rs 735. Meanwhile, Nomura has maintained a 'buy' call with a target of Rs 1,100.

Jefferies has maintained an 'underperform' rating on the Ramco Cements stock with a target of Rs 690.

Should you buy Cipla shares?

Nomura has maintained a 'neutral' rating on the Cipla stock with a target of Rs 1,535.
 
Citi has maintained a 'buy' call on Cipla shares with target of Rs 1,650.

Should you buy Gland Pharma shares?

Jefferies has maintained a 'buy' call on Gland Pharma shares with a target of Rs 2,240.

Nomura has maintained a 'neutral' rating on the Gland Pharma stock with a target of Rs 1,570.

Should you buy Nykaa shares?

Jefferies and HSBC have maintained a 'buy' call on the FSN E-Commerce Ventures (Nykaa) stock with a target of Rs 220 and Rs 250, respectively.

JPMorgan has maintained an 'underweight' rating on Nykaa shares with a target of Rs 138, while Macquarie has maintained an 'underperform' rating on the stock with a target of Rs 135. Meanwhile, Morgan Stanley has maintained an 'overweight' rating with a target of Rs 198.

Should you buy Paytm shares?

Jefferies has a 'hold' call on the One 97 Communications (Paytm) stock with a target of Rs 400. Citi, on the other side, has maintained a 'sell' call on the stock with a target of Rs 360.

JPMorgan has maintained an 'underweight' rating on One 97 Communications shares with a target of Rs 350, while Morgan Stanley has maintained an 'equal-weight' rating on the stock with a target of Rs 555.

Macquarie has maintained an 'underperform' rating on Paytm shares with a target of Rs 275.